Xellia Pharmaceuticals

Xellia Pharmaceutical Chemical manufactures antibiotics at its Budapest factory. UTB was commissioned with a major turnkey extension of the plant's process effluent treatment, built around biological treatment with membrane separation: equalisation, pH adjustment, drum filtration, pre-aeration, and high-loaded activated sludge with membrane filtration for sludge-water separation (MBR), followed by mechanical sludge thickening and storage. The work was a capacity extension, taking the plant from 360 to 600 m³/day.

• 600 m³/day
• 78,125 PE
• MEMBRATOR: high-loaded activated sludge with membrane separation
• Effluent to the communal sewer network
• Commissioned June 2020.